Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$96.41 - $126.61 $27,573 - $36,210
286 Added 0.09%
328,179 $33.9 Million
Q2 2023

Aug 09, 2023

BUY
$118.5 - $160.53 $20.7 Million - $28 Million
174,284 Added 113.46%
327,893 $39.8 Million
Q1 2023

May 08, 2023

SELL
$135.66 - $197.02 $6,918 - $10,048
-51 Reduced 0.03%
153,609 $23.6 Million
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $48,180 - $85,486
407 Added 0.27%
153,660 $27.6 Million
Q3 2022

Nov 07, 2022

BUY
$118.07 - $194.18 $111,458 - $183,305
944 Added 0.62%
153,253 $18.1 Million
Q2 2022

Aug 10, 2022

BUY
$117.13 - $176.59 $378,329 - $570,385
3,230 Added 2.17%
152,309 $21.8 Million
Q1 2022

May 12, 2022

BUY
$126.46 - $235.05 $37,179 - $69,104
294 Added 0.2%
149,079 $25.7 Million
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $209,786 - $342,345
929 Added 0.63%
148,785 $37.4 Million
Q3 2021

Nov 10, 2021

SELL
$221.9 - $484.47 $50.5 Million - $110 Million
-227,725 Reduced 60.63%
147,856 $56.9 Million
Q2 2021

Aug 11, 2021

SELL
$129.91 - $234.98 $62.8 Million - $114 Million
-483,231 Reduced 56.27%
375,581 $88.3 Million
Q1 2021

May 14, 2021

BUY
$109.18 - $185.98 $21.6 Million - $36.9 Million
198,264 Added 30.02%
858,812 $114 Million
Q4 2020

Feb 12, 2021

SELL
$65.74 - $169.86 $3.57 Million - $9.22 Million
-54,306 Reduced 7.6%
660,548 $69 Million
Q3 2020

Nov 12, 2020

SELL
$54.34 - $94.85 $137,860 - $240,634
-2,537 Reduced 0.35%
714,854 $50.4 Million
Q2 2020

Aug 12, 2020

BUY
$29.67 - $80.0 $21.3 Million - $57.4 Million
717,391 New
717,391 $44.5 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.